Abstract: A method of treating or inhibiting progress of dementia and/or macular degeneration in a mammal involves administering compositions containing siRNA to heme oxygenase-1 (HO-1) or heme oxygenase-2 (HO-2), a matrix metalloproteinase (MMP) inhibitor, a caspase inhibitor, or a metalloporphyrin in a manner that permits access to brain sites and/or the macula of the patient.
Type:
Application
Filed:
August 17, 2009
Publication date:
February 25, 2010
Applicants:
LOMA LINDA UNIVERSITY MEDICAL CENTER, GEORGE MASON UNIVERSITY, STONY BROOK UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventors:
Wolff Kirsch, Lance A. Liotta, William Van Nostrand, Harry V. Vinters, Virginia A. Espina
Abstract: A method of treating or inhibiting progress of dementia and/or macular degeneration in a mammal involves administering compositions containing siRNA to heme oxygenase-1 (HO-1) or heme oxygenase-2 (HO-2), a matrix metalloproteinase (MMP) inhibitor, a caspase inhibitor, or a metalloporphyrin in a manner that permits access to brain sites and/or the macula of the patient.
Type:
Application
Filed:
November 30, 2007
Publication date:
January 15, 2009
Applicants:
LOMA LINDA UNIVERSITY MEDICAL CENTER, GEORGE MASON UNIVERSITY, STONY BROOK UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventors:
Wolff Kirsch, Lance A. Liotta, William Van Nostrand, Harry V. Vinters, Virginia A. Espina